Robin Verjans
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cardiac Fibrosis and Remodeling
Papers in
-
- Circular RNAs in diseases 3
- RNA modifications and cancer 2
- RNA and protein synthesis mechanisms 1
- Congenital heart defects research 1
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 2
- Co-authors
- Marc van Bilsen (7 shared papers)Blanche Schroen (7 shared papers)Stéphane Heymans (3 shared papers)Wouter Verhesen (2 shared papers)Rick van Leeuwen (2 shared papers)T. J. Peters (1 shared paper)León J. De Windt (1 shared paper)Michiel T.H.M. Henkens (1 shared paper)
- Journals
- Hypertension (1 paper)Molecular Therapy — Nucleic Acids (1 paper)International review of cell and molecular biology (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- NetherlandsBelgiumItaly
In The Last Decade
Robin Verjans
9 papers receiving 279 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 147
- Cardiology and Cardiovascular Medicine 72
- Molecular Biology 168
- Aging 3
- Obstetrics and Gynecology 7
Countries citing papers authored by Robin Verjans
This map shows the geographic impact of Robin Verjans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Verjans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Verjans more than expected).
Fields of papers citing papers by Robin Verjans
This network shows the impact of papers produced by Robin Verjans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Verjans. The network helps show where Robin Verjans may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin Verjans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 138 | |
| 2 | 2018 | 38 | |
| 3 | 2019 | 29 | |
| 4 | 2019 | 27 | |
| 5 | 2017 | 27 | |
| 6 | 2020 | 12 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2018 | 1 |
About Robin Verjans
Robin Verjans is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Surgery and Public Health, Environmental and Occupational Health, having authored 9 papers that have together received 279 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (2 papers), RNA modifications and cancer (2 papers), RNA and protein synthesis mechanisms (1 paper), Biomedical Ethics and Regulation (1 paper), Congenital heart defects research (1 paper) and Cardiac Structural Anomalies and Repair (1 paper). The work is most often cited by research in Cancer Research (147 citations), Cardiology and Cardiovascular Medicine (72 citations), Molecular Biology (168 citations), Aging (3 citations) and Obstetrics and Gynecology (7 citations). Robin Verjans has collaborated with scholars based in Netherlands, Belgium and Italy. Frequent co-authors include Marc van Bilsen, Blanche Schroen, Stéphane Heymans, Wouter Verhesen, Rick van Leeuwen, T. J. Peters, León J. De Windt, Michiel T.H.M. Henkens, Arantxa González and Javier Beaumont. Their work appears in journals such as Hypertension, Molecular Therapy — Nucleic Acids, International review of cell and molecular biology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.